Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 15, 1992Annals of Internal Medicine

Long-Term Outcome of Patients with Relapsed and Refractory Germ Cell Tumors Treated with High-Dose Chemotherapy and Autologous Bone Marrow Rescue

View Full Paper
Ask AI
Bookmark
Share

Authors

EBE. Randolph BrounJewish HospitalCNCraig R. NicholsUniformed Services University of the Health SciencesPKPatricia KneeboneIndiana University Melvin and Bren Simon Comprehensive Cancer Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Broun et al. (1992) studied this question.

synapsesocial.com/papers/6a89bb5ea90c2f4c44fba4d3https://doi.org/10.7326/0003-4819-117-2-124
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.1989 · 353 citations
  2. 2Bone marrow transplant1989 · 3,410 citations
  3. 3Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.1991 · 116 citations
  4. 4High-dose chemotherapy and unpurged autologous bone marrow transplantation for acute leukemia in second or subsequent remission1990 · 10 citations
  5. 5A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support.1989 · 193 citations